Global Glucagon Drug Supply, Demand and Key Producers, 2024-2030

Description

The global Glucagon Drug market size is expected to reach $ 880.1 million by 2030, rising at a market growth of 5.8% CAGR during the forecast period (2024-2030).

The Glucagon injection market is driven by the rising prevalence of diabetes and hypoglycemia, and the growing awareness of the importance of emergency treatment for severe low blood sugar episodes. Glucagon injections are life-saving emergency medications used to rapidly raise blood sugar levels in individuals experiencing severe hypoglycemia. The rise in the global diabetic population and the need for effective management of insulin-related conditions contribute to market growth as glucagon injections offer a crucial solution in emergency situations. Moreover, advancements in device design and the development of user-friendly glucagon delivery systems have improved the accessibility and ease of administration. However, the market also faces challenges, including the need for patient education on proper administration and storage of glucagon injections, and the complexity of the regulatory landscape for medical emergency medications. Additionally, addressing affordability and expanding access to glucagon injections in various regions can pose obstacles for manufacturers. To succeed, companies must focus on research and development to offer innovative and reliable glucagon injection solutions, collaborate with healthcare providers to promote awareness and training, and address the challenges to meet the increasing demand for effective and life-saving emergency treatments for hypoglycemia.

Glucagon is a metabolic hormone secreted by the pancreas that raises blood glucose levels by causing the liver to rapidly convert glycogen (the stored form of glucose) into glucose, which is then released into the bloodstream.  Glucagon and insulin are two critical hormones in a glycemic control system that keeps blood glucose at the right level in healthy individual. Glucagon is a medicine which used to treat severe low blood sugar (hypoglycemia). Glucagon works by telling your body to release sugar (glucose) into the bloodstream to bring the blood sugar level back up.

This report studies the global Glucagon Drug production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Glucagon Drug, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Glucagon Drug that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Glucagon Drug total production and demand, 2019-2030, (K Units)
Global Glucagon Drug total production value, 2019-2030, (USD Million)
Global Glucagon Drug production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Glucagon Drug consumption by region & country, CAGR, 2019-2030 & (K Units)
U.S. VS China: Glucagon Drug domestic production, consumption, key domestic manufacturers and share
Global Glucagon Drug production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)
Global Glucagon Drug production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Glucagon Drug production by Application production, value, CAGR, 2019-2030, (USD Million) & (K Units).

This reports profiles key players in the global Glucagon Drug market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novo Nordisk, Eli Lilly, Fresenius Kabi, Torrent Labs, Amphastar Pharmaceuticals and Xeris Pharmaceuticals, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Glucagon Drug market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Glucagon Drug Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Glucagon Drug Market, Segmentation by Type
    Vials
    Prefilled

Global Glucagon Drug Market, Segmentation by Application
    Hospital
    Pharmacy

Companies Profiled:
    Novo Nordisk
    Eli Lilly
    Fresenius Kabi
    Torrent Labs
    Amphastar Pharmaceuticals
    Xeris Pharmaceuticals

Key Questions Answered
1. How big is the global Glucagon Drug market?
2. What is the demand of the global Glucagon Drug market?
3. What is the year over year growth of the global Glucagon Drug market?
4. What is the production and production value of the global Glucagon Drug market?
5. Who are the key producers in the global Glucagon Drug market?

Table of Contents

1 Supply Summary
    1.1 Glucagon Drug Introduction
    1.2 World Glucagon Drug Supply & Forecast
        1.2.1 World Glucagon Drug Production Value (2019 & 2023 & 2030)
        1.2.2 World Glucagon Drug Production (2019-2030)
        1.2.3 World Glucagon Drug Pricing Trends (2019-2030)
    1.3 World Glucagon Drug Production by Region (Based on Production Site)
        1.3.1 World Glucagon Drug Production Value by Region (2019-2030)
        1.3.2 World Glucagon Drug Production by Region (2019-2030)
        1.3.3 World Glucagon Drug Average Price by Region (2019-2030)
        1.3.4 North America Glucagon Drug Production (2019-2030)
        1.3.5 Europe Glucagon Drug Production (2019-2030)
        1.3.6 China Glucagon Drug Production (2019-2030)
        1.3.7 Japan Glucagon Drug Production (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Glucagon Drug Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Glucagon Drug Major Market Trends

2 Demand Summary
    2.1 World Glucagon Drug Demand (2019-2030)
    2.2 World Glucagon Drug Consumption by Region
        2.2.1 World Glucagon Drug Consumption by Region (2019-2024)
        2.2.2 World Glucagon Drug Consumption Forecast by Region (2025-2030)
    2.3 United States Glucagon Drug Consumption (2019-2030)
    2.4 China Glucagon Drug Consumption (2019-2030)
    2.5 Europe Glucagon Drug Consumption (2019-2030)
    2.6 Japan Glucagon Drug Consumption (2019-2030)
    2.7 South Korea Glucagon Drug Consumption (2019-2030)
    2.8 ASEAN Glucagon Drug Consumption (2019-2030)
    2.9 India Glucagon Drug Consumption (2019-2030)

3 World Glucagon Drug Manufacturers Competitive Analysis
    3.1 World Glucagon Drug Production Value by Manufacturer (2019-2024)
    3.2 World Glucagon Drug Production by Manufacturer (2019-2024)
    3.3 World Glucagon Drug Average Price by Manufacturer (2019-2024)
    3.4 Glucagon Drug Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Glucagon Drug Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Glucagon Drug in 2023
        3.5.3 Global Concentration Ratios (CR8) for Glucagon Drug in 2023
    3.6 Glucagon Drug Market: Overall Company Footprint Analysis
        3.6.1 Glucagon Drug Market: Region Footprint
        3.6.2 Glucagon Drug Market: Company Product Type Footprint
        3.6.3 Glucagon Drug Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Glucagon Drug Production Value Comparison
        4.1.1 United States VS China: Glucagon Drug Production Value Comparison (2019 & 2023 & 2030)
        4.1.2 United States VS China: Glucagon Drug Production Value Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States VS China: Glucagon Drug Production Comparison
        4.2.1 United States VS China: Glucagon Drug Production Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Glucagon Drug Production Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States VS China: Glucagon Drug Consumption Comparison
        4.3.1 United States VS China: Glucagon Drug Consumption Comparison (2019 & 2023 & 2030)
        4.3.2 United States VS China: Glucagon Drug Consumption Market Share Comparison (2019 & 2023 & 2030)
    4.4 United States Based Glucagon Drug Manufacturers and Market Share, 2019-2024
        4.4.1 United States Based Glucagon Drug Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Glucagon Drug Production Value (2019-2024)
        4.4.3 United States Based Manufacturers Glucagon Drug Production (2019-2024)
    4.5 China Based Glucagon Drug Manufacturers and Market Share
        4.5.1 China Based Glucagon Drug Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Glucagon Drug Production Value (2019-2024)
        4.5.3 China Based Manufacturers Glucagon Drug Production (2019-2024)
    4.6 Rest of World Based Glucagon Drug Manufacturers and Market Share, 2019-2024
        4.6.1 Rest of World Based Glucagon Drug Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Glucagon Drug Production Value (2019-2024)
        4.6.3 Rest of World Based Manufacturers Glucagon Drug Production (2019-2024)

5 Market Analysis by Type
    5.1 World Glucagon Drug Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Vials
        5.2.2 Prefilled
    5.3 Market Segment by Type
        5.3.1 World Glucagon Drug Production by Type (2019-2030)
        5.3.2 World Glucagon Drug Production Value by Type (2019-2030)
        5.3.3 World Glucagon Drug Average Price by Type (2019-2030)

6 Market Analysis by Application
    6.1 World Glucagon Drug Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Hospital
        6.2.2 Pharmacy
    6.3 Market Segment by Application
        6.3.1 World Glucagon Drug Production by Application (2019-2030)
        6.3.2 World Glucagon Drug Production Value by Application (2019-2030)
        6.3.3 World Glucagon Drug Average Price by Application (2019-2030)

7 Company Profiles
    7.1 Novo Nordisk
        7.1.1 Novo Nordisk Details
        7.1.2 Novo Nordisk Major Business
        7.1.3 Novo Nordisk Glucagon Drug Product and Services
        7.1.4 Novo Nordisk Glucagon Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.1.5 Novo Nordisk Recent Developments/Updates
        7.1.6 Novo Nordisk Competitive Strengths & Weaknesses
    7.2 Eli Lilly
        7.2.1 Eli Lilly Details
        7.2.2 Eli Lilly Major Business
        7.2.3 Eli Lilly Glucagon Drug Product and Services
        7.2.4 Eli Lilly Glucagon Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.2.5 Eli Lilly Recent Developments/Updates
        7.2.6 Eli Lilly Competitive Strengths & Weaknesses
    7.3 Fresenius Kabi
        7.3.1 Fresenius Kabi Details
        7.3.2 Fresenius Kabi Major Business
        7.3.3 Fresenius Kabi Glucagon Drug Product and Services
        7.3.4 Fresenius Kabi Glucagon Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.3.5 Fresenius Kabi Recent Developments/Updates
        7.3.6 Fresenius Kabi Competitive Strengths & Weaknesses
    7.4 Torrent Labs
        7.4.1 Torrent Labs Details
        7.4.2 Torrent Labs Major Business
        7.4.3 Torrent Labs Glucagon Drug Product and Services
        7.4.4 Torrent Labs Glucagon Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.4.5 Torrent Labs Recent Developments/Updates
        7.4.6 Torrent Labs Competitive Strengths & Weaknesses
    7.5 Amphastar Pharmaceuticals
        7.5.1 Amphastar Pharmaceuticals Details
        7.5.2 Amphastar Pharmaceuticals Major Business
        7.5.3 Amphastar Pharmaceuticals Glucagon Drug Product and Services
        7.5.4 Amphastar Pharmaceuticals Glucagon Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.5.5 Amphastar Pharmaceuticals Recent Developments/Updates
        7.5.6 Amphastar Pharmaceuticals Competitive Strengths & Weaknesses
    7.6 Xeris Pharmaceuticals
        7.6.1 Xeris Pharmaceuticals Details
        7.6.2 Xeris Pharmaceuticals Major Business
        7.6.3 Xeris Pharmaceuticals Glucagon Drug Product and Services
        7.6.4 Xeris Pharmaceuticals Glucagon Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.6.5 Xeris Pharmaceuticals Recent Developments/Updates
        7.6.6 Xeris Pharmaceuticals Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Glucagon Drug Industry Chain
    8.2 Glucagon Drug Upstream Analysis
        8.2.1 Glucagon Drug Core Raw Materials
        8.2.2 Main Manufacturers of Glucagon Drug Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Glucagon Drug Production Mode
    8.6 Glucagon Drug Procurement Model
    8.7 Glucagon Drug Industry Sales Model and Sales Channels
        8.7.1 Glucagon Drug Sales Model
        8.7.2 Glucagon Drug Typical Customers

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Glucagon Drug Production Value by Region (2019, 2023 and 2030) & (USD Million)
    Table 2. World Glucagon Drug Production Value by Region (2019-2024) & (USD Million)
    Table 3. World Glucagon Drug Production Value by Region (2025-2030) & (USD Million)
    Table 4. World Glucagon Drug Production Value Market Share by Region (2019-2024)
    Table 5. World Glucagon Drug Production Value Market Share by Region (2025-2030)
    Table 6. World Glucagon Drug Production by Region (2019-2024) & (K Units)
    Table 7. World Glucagon Drug Production by Region (2025-2030) & (K Units)
    Table 8. World Glucagon Drug Production Market Share by Region (2019-2024)
    Table 9. World Glucagon Drug Production Market Share by Region (2025-2030)
    Table 10. World Glucagon Drug Average Price by Region (2019-2024) & (US$/Unit)
    Table 11. World Glucagon Drug Average Price by Region (2025-2030) & (US$/Unit)
    Table 12. Glucagon Drug Major Market Trends
    Table 13. World Glucagon Drug Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Units)
    Table 14. World Glucagon Drug Consumption by Region (2019-2024) & (K Units)
    Table 15. World Glucagon Drug Consumption Forecast by Region (2025-2030) & (K Units)
    Table 16. World Glucagon Drug Production Value by Manufacturer (2019-2024) & (USD Million)
    Table 17. Production Value Market Share of Key Glucagon Drug Producers in 2023
    Table 18. World Glucagon Drug Production by Manufacturer (2019-2024) & (K Units)
    Table 19. Production Market Share of Key Glucagon Drug Producers in 2023
    Table 20. World Glucagon Drug Average Price by Manufacturer (2019-2024) & (US$/Unit)
    Table 21. Global Glucagon Drug Company Evaluation Quadrant
    Table 22. World Glucagon Drug Industry Rank of Major Manufacturers, Based on Production Value in 2023
    Table 23. Head Office and Glucagon Drug Production Site of Key Manufacturer
    Table 24. Glucagon Drug Market: Company Product Type Footprint
    Table 25. Glucagon Drug Market: Company Product Application Footprint
    Table 26. Glucagon Drug Competitive Factors
    Table 27. Glucagon Drug New Entrant and Capacity Expansion Plans
    Table 28. Glucagon Drug Mergers & Acquisitions Activity
    Table 29. United States VS China Glucagon Drug Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 30. United States VS China Glucagon Drug Production Comparison, (2019 & 2023 & 2030) & (K Units)
    Table 31. United States VS China Glucagon Drug Consumption Comparison, (2019 & 2023 & 2030) & (K Units)
    Table 32. United States Based Glucagon Drug Manufacturers, Headquarters and Production Site (States, Country)
    Table 33. United States Based Manufacturers Glucagon Drug Production Value, (2019-2024) & (USD Million)
    Table 34. United States Based Manufacturers Glucagon Drug Production Value Market Share (2019-2024)
    Table 35. United States Based Manufacturers Glucagon Drug Production (2019-2024) & (K Units)
    Table 36. United States Based Manufacturers Glucagon Drug Production Market Share (2019-2024)
    Table 37. China Based Glucagon Drug Manufacturers, Headquarters and Production Site (Province, Country)
    Table 38. China Based Manufacturers Glucagon Drug Production Value, (2019-2024) & (USD Million)
    Table 39. China Based Manufacturers Glucagon Drug Production Value Market Share (2019-2024)
    Table 40. China Based Manufacturers Glucagon Drug Production (2019-2024) & (K Units)
    Table 41. China Based Manufacturers Glucagon Drug Production Market Share (2019-2024)
    Table 42. Rest of World Based Glucagon Drug Manufacturers, Headquarters and Production Site (States, Country)
    Table 43. Rest of World Based Manufacturers Glucagon Drug Production Value, (2019-2024) & (USD Million)
    Table 44. Rest of World Based Manufacturers Glucagon Drug Production Value Market Share (2019-2024)
    Table 45. Rest of World Based Manufacturers Glucagon Drug Production (2019-2024) & (K Units)
    Table 46. Rest of World Based Manufacturers Glucagon Drug Production Market Share (2019-2024)
    Table 47. World Glucagon Drug Production Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 48. World Glucagon Drug Production by Type (2019-2024) & (K Units)
    Table 49. World Glucagon Drug Production by Type (2025-2030) & (K Units)
    Table 50. World Glucagon Drug Production Value by Type (2019-2024) & (USD Million)
    Table 51. World Glucagon Drug Production Value by Type (2025-2030) & (USD Million)
    Table 52. World Glucagon Drug Average Price by Type (2019-2024) & (US$/Unit)
    Table 53. World Glucagon Drug Average Price by Type (2025-2030) & (US$/Unit)
    Table 54. World Glucagon Drug Production Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 55. World Glucagon Drug Production by Application (2019-2024) & (K Units)
    Table 56. World Glucagon Drug Production by Application (2025-2030) & (K Units)
    Table 57. World Glucagon Drug Production Value by Application (2019-2024) & (USD Million)
    Table 58. World Glucagon Drug Production Value by Application (2025-2030) & (USD Million)
    Table 59. World Glucagon Drug Average Price by Application (2019-2024) & (US$/Unit)
    Table 60. World Glucagon Drug Average Price by Application (2025-2030) & (US$/Unit)
    Table 61. Novo Nordisk Basic Information, Manufacturing Base and Competitors
    Table 62. Novo Nordisk Major Business
    Table 63. Novo Nordisk Glucagon Drug Product and Services
    Table 64. Novo Nordisk Glucagon Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 65. Novo Nordisk Recent Developments/Updates
    Table 66. Novo Nordisk Competitive Strengths & Weaknesses
    Table 67. Eli Lilly Basic Information, Manufacturing Base and Competitors
    Table 68. Eli Lilly Major Business
    Table 69. Eli Lilly Glucagon Drug Product and Services
    Table 70. Eli Lilly Glucagon Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 71. Eli Lilly Recent Developments/Updates
    Table 72. Eli Lilly Competitive Strengths & Weaknesses
    Table 73. Fresenius Kabi Basic Information, Manufacturing Base and Competitors
    Table 74. Fresenius Kabi Major Business
    Table 75. Fresenius Kabi Glucagon Drug Product and Services
    Table 76. Fresenius Kabi Glucagon Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 77. Fresenius Kabi Recent Developments/Updates
    Table 78. Fresenius Kabi Competitive Strengths & Weaknesses
    Table 79. Torrent Labs Basic Information, Manufacturing Base and Competitors
    Table 80. Torrent Labs Major Business
    Table 81. Torrent Labs Glucagon Drug Product and Services
    Table 82. Torrent Labs Glucagon Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 83. Torrent Labs Recent Developments/Updates
    Table 84. Torrent Labs Competitive Strengths & Weaknesses
    Table 85. Amphastar Pharmaceuticals Basic Information, Manufacturing Base and Competitors
    Table 86. Amphastar Pharmaceuticals Major Business
    Table 87. Amphastar Pharmaceuticals Glucagon Drug Product and Services
    Table 88. Amphastar Pharmaceuticals Glucagon Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 89. Amphastar Pharmaceuticals Recent Developments/Updates
    Table 90. Xeris Pharmaceuticals Basic Information, Manufacturing Base and Competitors
    Table 91. Xeris Pharmaceuticals Major Business
    Table 92. Xeris Pharmaceuticals Glucagon Drug Product and Services
    Table 93. Xeris Pharmaceuticals Glucagon Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 94. Global Key Players of Glucagon Drug Upstream (Raw Materials)
    Table 95. Glucagon Drug Typical Customers
    Table 96. Glucagon Drug Typical Distributors
List of Figure
    Figure 1. Glucagon Drug Picture
    Figure 2. World Glucagon Drug Production Value: 2019 & 2023 & 2030, (USD Million)
    Figure 3. World Glucagon Drug Production Value and Forecast (2019-2030) & (USD Million)
    Figure 4. World Glucagon Drug Production (2019-2030) & (K Units)
    Figure 5. World Glucagon Drug Average Price (2019-2030) & (US$/Unit)
    Figure 6. World Glucagon Drug Production Value Market Share by Region (2019-2030)
    Figure 7. World Glucagon Drug Production Market Share by Region (2019-2030)
    Figure 8. North America Glucagon Drug Production (2019-2030) & (K Units)
    Figure 9. Europe Glucagon Drug Production (2019-2030) & (K Units)
    Figure 10. China Glucagon Drug Production (2019-2030) & (K Units)
    Figure 11. Japan Glucagon Drug Production (2019-2030) & (K Units)
    Figure 12. Glucagon Drug Market Drivers
    Figure 13. Factors Affecting Demand
    Figure 14. World Glucagon Drug Consumption (2019-2030) & (K Units)
    Figure 15. World Glucagon Drug Consumption Market Share by Region (2019-2030)
    Figure 16. United States Glucagon Drug Consumption (2019-2030) & (K Units)
    Figure 17. China Glucagon Drug Consumption (2019-2030) & (K Units)
    Figure 18. Europe Glucagon Drug Consumption (2019-2030) & (K Units)
    Figure 19. Japan Glucagon Drug Consumption (2019-2030) & (K Units)
    Figure 20. South Korea Glucagon Drug Consumption (2019-2030) & (K Units)
    Figure 21. ASEAN Glucagon Drug Consumption (2019-2030) & (K Units)
    Figure 22. India Glucagon Drug Consumption (2019-2030) & (K Units)
    Figure 23. Producer Shipments of Glucagon Drug by Manufacturer Revenue ($MM) and Market Share (%): 2023
    Figure 24. Global Four-firm Concentration Ratios (CR4) for Glucagon Drug Markets in 2023
    Figure 25. Global Four-firm Concentration Ratios (CR8) for Glucagon Drug Markets in 2023
    Figure 26. United States VS China: Glucagon Drug Production Value Market Share Comparison (2019 & 2023 & 2030)
    Figure 27. United States VS China: Glucagon Drug Production Market Share Comparison (2019 & 2023 & 2030)
    Figure 28. United States VS China: Glucagon Drug Consumption Market Share Comparison (2019 & 2023 & 2030)
    Figure 29. United States Based Manufacturers Glucagon Drug Production Market Share 2023
    Figure 30. China Based Manufacturers Glucagon Drug Production Market Share 2023
    Figure 31. Rest of World Based Manufacturers Glucagon Drug Production Market Share 2023
    Figure 32. World Glucagon Drug Production Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 33. World Glucagon Drug Production Value Market Share by Type in 2023
    Figure 34. Vials
    Figure 35. Prefilled
    Figure 36. World Glucagon Drug Production Market Share by Type (2019-2030)
    Figure 37. World Glucagon Drug Production Value Market Share by Type (2019-2030)
    Figure 38. World Glucagon Drug Average Price by Type (2019-2030) & (US$/Unit)
    Figure 39. World Glucagon Drug Production Value by Application, (USD Million), 2019 & 2023 & 2030
    Figure 40. World Glucagon Drug Production Value Market Share by Application in 2023
    Figure 41. Hospital
    Figure 42. Pharmacy
    Figure 43. World Glucagon Drug Production Market Share by Application (2019-2030)
    Figure 44. World Glucagon Drug Production Value Market Share by Application (2019-2030)
    Figure 45. World Glucagon Drug Average Price by Application (2019-2030) & (US$/Unit)
    Figure 46. Glucagon Drug Industry Chain
    Figure 47. Glucagon Drug Procurement Model
    Figure 48. Glucagon Drug Sales Model
    Figure 49. Glucagon Drug Sales Channels, Direct Sales, and Distribution
    Figure 50. Methodology
    Figure 51. Research Process and Data Source

Companies Mentioned

Novo Nordisk
Eli Lilly
Fresenius Kabi
Torrent Labs
Amphastar Pharmaceuticals
Xeris Pharmaceuticals